welcome to DuchenneXchange
- a positively charged Duchenne muscular dystrophy community.- join today!
- login
Abstracts & Posters
The evaluation of bone age in patients with Duchenne muscular dystrophy on long-term glucocorticoid treatment
source: Neuromuscular Disorders
year: 2015
authors: E. Annexstad, J.Westvik, A. Myhre, J. Bollerslev, I. Holm, M.Rasmussen
summary/abstract:Long-term treatment with glucocorticoids (GCs) has a well-established effect on ambulation, prevention of scoliosis and preserved respiratory function in patients with Duchenne muscular dystrophy (DMD). However, as a new generation of GC treated DMD boys grow up to become young adults, long-term side effects of this treatment need to be addressed. A nationwide longitudinal study of paediatric DMD patients in Norway was set up to assess genotype/phenotype correlations; growth; puberty; bone health and quality of life.
organization: Centre for Congenital Neuromuscular Disorders, Norway; Oslo University Hospital, NorwayDOI: 10.1016/j.nmd.2015.06.050
read more
rareRelated
-
Budding Journalist Hawken Miller Offers Advice on Living With DuchenneAt 21, Hawken Miller certainly doesn’t...
-
Bone health in boys with Duchenne Muscular Dystrophy on long-term daily deflazacort therapyQuality of life in Duchenne Muscular Dys...
-
Bone health measures in glucocorticoid-treated ambulatory boys with Duchenne muscular dystrophyOsteoporosis is a major problem in boys ...
-
Developing standardized corticosteroid treatment for Duchenne muscular dystrophyDespite corticosteroids being the only t...
-
ICER Document Reviews Effectiveness of 3 Duchenne MD TherapiesThe Institute for Clinical and Economic ...
-
Potential Mechanisms for Prolonged Loss of Ambulation with Deflazacort in Duchenne Muscular Dystrophy – Tolera...Objective: To summarize prolonged loss ...
-
Neurodevelopmental Needs in Young Boys with Duchenne Muscular Dystrophy (DMD): Observations from the Cooperative Int...Introduction: Duchenne muscular dystroph...